Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic value and influencing factors of Tegoprazan test in GERD
ChiCTR2400093370Phase 4Recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of tegoprazan in gastroesophageal reflux disease (GERD), sponsored by Third People's Hospital of Chengdu. Primary endpoints: Sensitivity of Tegoprazan-test for GERD diagnosis and Specificity of Tegoprazan-test for GERD diagnosis. Started Dec 2024; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ChiCTR2400093370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093370.